Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/838
High-dose intravenous immunoglobulin as a therapeutic option for deteriorating patients with Coronavirus Disease 2019
Cao, W
Liu, X
Bai, T
Fan, H
Hong, K
Song, H
Han, Y
Lin, L
Ruan, L
Li, T
Acceso Abierto
Atribución-NoComercial-SinDerivadas
Abstract The outbreak of Coronavirus Disease 2019 (COVID-19) has spread rapidly in China. Till now, no definite effective treatment has been identified. We reported on three patients of severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
Open Forum Infectious Diseases
2020
Preimpreso
https://coronavirus.1science.com/item/e80ab87c5b9e3010cc01545581f8025aa939b7b7
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
102791.pdf431.98 kBAdobe PDFView/Open